← Holders
Sio Capital Management, LLC
What Sio Capital Management, LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1482416 · Filed Nov 16, 2026
- Positions
- 55
- Reported value
- $528.5M
- Opened
- 15
- Closed
- 19
- Other managers included
- 0
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$395.2M51 positions
- Dec 31, 2025$635.7M68 positions
- Mar 31, 2026$697.3M76 positions
- Jun 30, 2026$604.3M59 positions
- Sep 30, 2026$528.5M55 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
AVRAnteris Technologies Global Corp. | 5.2M | −6.6% | $40.2M | 7.6% |
GMEDGlobus Medical Inc | 476.1K | +57.7% | $35.7M | 6.7% |
GSKGSK PLC | 671.1K | +53.7% | $32.3M | 6.1% |
ICLRIcon PLC | 141K | +59.9% | $24M | 4.5% |
SENSSenseonics Holdings, Inc. | 2.3M | +43.8% | $23.3M | 4.4% |
| 150K | New | $21.8M | 4.1% | |
MRKMerck & Co., Inc. | 145.5K | New | $21.1M | 4% |
IDYAIDEAYA Biosciences, Inc. | 500.1K | +4.1% | $19.2M | 3.6% |
| 600K | New | $17.1M | 3.2% | |
| 1.2M | ±0% | $15.1M | 2.9% | |
SNYSanofi | 356.2K | −2.2% | $14.7M | 2.8% |
ALLOAllogene Therapeutics, Inc. | 9.1M | −31.7% | $14.6M | 2.8% |
MMSMaximus, Inc. | 268.3K | −62.5% | $14.3M | 2.7% |
RLMDRelmada Therapeutics, Inc. | 3.6M | +261.7% | $13.7M | 2.6% |
VTRSViatris Inc | 755.5K | −20.8% | $13.4M | 2.5% |
AVAHAveanna Healthcare Holdings, Inc. | 1M | +174.3% | $12.6M | 2.4% |
REPLReplimune Group, Inc. | 865.3K | New | $11.5M | 2.2% |
TNGXTango Therapeutics, Inc. | 428.9K | +105.7% | $10.7M | 2% |
ANIPANI Pharmaceuticals Inc | 146.3K | +50.3% | $10.6M | 2% |
BMRNBioMarin Pharmaceutical Inc | 174.3K | New | $10.5M | 2% |
CELCCelcuity Inc. | 126.3K | +14.8% | $10M | 1.9% |
AZNAstraZeneca PLC | 61.8K | New | $10M | 1.9% |
RAPPRapport Therapeutics, Inc. | 291.2K | −5.3% | $9.8M | 1.9% |
VIRVir Biotechnology, Inc. | 873.4K | −18.8% | $9.8M | 1.8% |
CICigna Group | 33.9K | −41.2% | $9.2M | 1.7% |
COOCooper Companies, Inc. | 158.1K | New | $8.9M | 1.7% |
LQDALiquidia Corp | 282K | New | $8.5M | 1.6% |
HELPHelus Pharma Inc. | 561.3K | −56.8% | $6.9M | 1.3% |
TARAProtara Therapeutics, Inc. | 2M | +3.6% | $6.1M | 1.1% |
PMVPPMV Pharmaceuticals, Inc. | 3.6M | +38.0% | $6.1M | 1.1% |
AQSTAquestive Therapeutics, Inc. | 1.3M | −14.0% | $5.9M | 1.1% |
PTCTPTC Therapeutics, Inc. | 82.9K | New | $5.4M | 1% |
CRBPCorbus Pharmaceuticals Holdings, Inc. | 766.4K | New | $5.2M | 1% |
RNAQURainier Acquisition Corp | 500K | New | $5.1M | 1% |
| 44.7K | New | $4.7M | 0.9% | |
QTTBQ32 Bio Inc. | 529.2K | New | $4.4M | 0.8% |
SERSerina Therapeutics, Inc. | 2M | +100.0% | $4M | 0.8% |
DRUGBright Minds Biosciences Inc. | 75.2K | +1.6% | $3.7M | 0.7% |
SVRASavara Inc | 657.1K | +6.4% | $3.4M | 0.6% |
OKUROnKure Therapeutics, Inc. | 1.1M | +0.4% | $3M | 0.6% |
ANTXAN2 Therapeutics, Inc. | 548.1K | +3.4% | $2.9M | 0.6% |
IMNMImmunome Inc. | 132.1K | +6.4% | $2.8M | 0.5% |
ZBIOZenas BioPharma, Inc. | 95.5K | −54.2% | $2.6M | 0.5% |
OVIDOvid Therapeutics Inc. | 1M | ±0% | $2.5M | 0.5% |
ALGSAligos Therapeutics, Inc. | 327.2K | ±0% | $1.8M | 0.3% |
FULCFulcrum Therapeutics, Inc. | 481.6K | New | $1.8M | 0.3% |
ALHCAlignment Healthcare, Inc. | 184.4K | New | $1.5M | 0.3% |
XLOXilio Therapeutics, Inc. | 152.5K | ±0% | $1.4M | 0.3% |
EYPTEyePoint, Inc. | 373.7K | −40.0% | $1.2M | 0.2% |
QTIQT Imaging Holdings, Inc. | 440.4K | +2,790.8% | $1.1M | 0.2% |
IBIOiBio, Inc. | 904.3K | ±0% | $1.1M | 0.2% |
TELATELA Bio, Inc. | 636.3K | ±0% | $731.7K | 0.1% |
ENVBEnveric Biosciences, Inc. | 330K | +83.3% | $490.1K | 0.1% |
NMTCNeuroone Medical Technologies Corp | 82.8K | ±0% | $85.3K | 0.1% |
MODDModular Medical, Inc. | 26.2K | ±0% | $52.4K | 0.1% |